Search results for Ponatinib

128 hits were found for Ponatinib

# Family MCID Name MIFTS Score
1
c LKM063 Leukemia, Chronic Myeloid 72 0.627
2
P MYL006 Myeloid Leukemia 60 0.617
3
P LKM002 Leukemia 68 0.491
4
P LKM062 Leukemia, Acute Lymphoblastic 69 0.422
5
c CHR064 Chronic Monocytic Leukemia 33 0.390
6
LYM040 Lymphoblastic Lymphoma 54 0.290
7
P LYM118 Lymphoma 68 0.286
8
LYM019 Lymphosarcoma 46 0.286
9
P TRN020 Turner Syndrome 67 0.235
10
c LKM061 Leukemia, Acute Myeloid 84 0.214
11
MYL031 Myeloproliferative Neoplasm 66 0.196
12
SPN041 Spinal Cord Disease 56 0.177
13
RTN193 Retinitis Pigmentosa and Erythrocytic Microcytosis 52 0.177
14
MRG013 Mirage Syndrome 43 0.177
15
BNM001 Bone Marrow Cancer 43 0.177
16
P LNG032 Lung Cancer 98 0.170
17
ACT113 Acute Myeloblastic Leukemia with Maturation 46 0.170
18
c SML038 Small Cell Cancer of the Lung 65 0.163
19
P EXN002 Exanthem 57 0.147
20
FCT007 Factor Vii Deficiency 67 0.139
21
THY029 Thyroid Carcinoma 59 0.139
22
LNG031 Lung Benign Neoplasm 51 0.139
23
GLB015 Glioblastoma Multiforme 75 0.130
24
c ACT073 Acute Leukemia 58 0.130
25
IMM167 Immune Deficiency Disease 78 0.120
26
GST019 Gastrointestinal Stromal Tumor 78 0.120
27
c NRD033 Neurodegeneration with Brain Iron Accumulation 2a 69 0.120
28
CRB039 Cerebrovascular Disease 67 0.120
29
THY111 Thyroid Carcinoma, Familial Medullary 67 0.120
30
P LYM033 Lymphoproliferative Syndrome 59 0.120
31
c ATM082 Autoimmune Lymphoproliferative Syndrome, Type V 54 0.120
32
P LYM024 Lymphatic System Disease 48 0.120
33
CMP090 Complement Component 3 Deficiency, Autosomal Recessive 45 0.120
34
IMM136 Immune System Disease 45 0.120
35
P HYP073 Hypersensitivity Reaction Type Iv Disease 44 0.120
36
SYS070 Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood 36 0.120
37
STR067 Stroke, Ischemic 81 0.110
38
P MYC007 Myocardial Infarction 70 0.110
39
DWN001 Down Syndrome 70 0.110
40
P HYP086 Hypothyroidism 69 0.110
41
PRG017 Paraganglioma and Gastric Stromal Sarcoma 61 0.110
42
THY122 Thyroid Gland Cancer 57 0.110
43
THY030 Thyroid Gland Disease 52 0.110
44
48X005 48,xyyy 39 0.110
45
P HPT023 Hepatocellular Carcinoma 100 0.098
46
END057 Endometrial Cancer 74 0.098
47
P NRB001 Neuroblastoma 72 0.098
48
P THR014 Thrombocytopenia 67 0.098
49
HMT002 Hematologic Cancer 62 0.098
50
P 8P1002 8p11 Myeloproliferative Syndrome 39 0.098
51
P GLM040 Glioma Susceptibility 1 81 0.085
52
SQM013 Squamous Cell Carcinoma, Head and Neck 80 0.085
53
P LNG064 Lung Cancer Susceptibility 3 78 0.085
54
P GRF003 Graft-Versus-Host Disease 72 0.085
55
MYL009 Myelodysplastic Syndrome 70 0.085
56
P ADN016 Adenocarcinoma 64 0.085
57
SQM006 Squamous Cell Carcinoma 60 0.085
58
P PTY003 Pityriasis Rubra Pilaris 58 0.085
59
CMR002 Coumarin Resistance 56 0.085
60
NRN004 Neuroendocrine Tumor 55 0.085
61
P ICH004 Ichthyosis 54 0.085
62
47X002 47,xyy 49 0.085
63
GST049 Gastrointestinal System Cancer 49 0.085
64
NRN001 Neuroendocrine Carcinoma 47 0.085
65
GST071 Gastrointestinal Carcinoma 47 0.085
66
c PRM038 Primary Agammaglobulinemia 44 0.085
67
TRP009 Triple X Syndrome 42 0.085
68
MSN004 Mesenchymal Cell Neoplasm 41 0.085
69
c JVN004 Juvenile Myelomonocytic Leukemia 67 0.069
70
c RHB024 Rhabdomyosarcoma 2 67 0.069
71
ATH013 Atherosclerosis Susceptibility 65 0.069
72
P MST009 Mastocytosis 64 0.069
73
P RHB003 Rhabdomyosarcoma 63 0.069
74
c ATS013 Autosomal Recessive Congenital Ichthyosis 63 0.069
75
P NTR004 Neutropenia 63 0.069
76
c SYS004 Systemic Mastocytosis 63 0.069
77
P CHR285 Chronic Myelomonocytic Leukemia 60 0.069
78
P CRD246 Cardiovascular System Disease 57 0.069
79
c LKM060 Leukemia, Acute Lymphoblastic 3 56 0.069
80
c CHR418 Chronic Leukemia 49 0.069
81
P MST002 Mast-Cell Leukemia 49 0.069
82
CHR563 Chronic Eosinophilic Leukemia 48 0.069
83
MXD050 Mixed Phenotype Acute Leukemia 43 0.069
84
PDG002 Pdgfrb-Associated Chronic Eosinophilic Leukemia 27 0.069
85
P CLR023 Colorectal Cancer 99 0.049
86
PLM134 Pulmonary Fibrosis, Idiopathic 77 0.049
87
c PLM164 Pulmonary Hypertension, Primary, 1 75 0.049
88
SVR004 Severe Combined Immunodeficiency 73 0.049
89
P RTN024 Retinoblastoma 73 0.049
90
MYL005 Myelofibrosis 70 0.049
91
c MLT160 Multiple Endocrine Neoplasia, Type Iia 70 0.049
92
CNG034 Congestive Heart Failure 69 0.049
93
P LVR013 Liver Disease 68 0.049
94
P INF038 Influenza 68 0.049
95
P CRB048 Cerebral Cavernous Malformations 67 0.049
96
P PLM037 Pulmonary Hypertension 67 0.049
97
P PLM036 Pulmonary Fibrosis 65 0.049
98
P HYP750 Hypertriglyceridemia, Familial 62 0.049
99
P VSC011 Vasculitis 62 0.049
100
NRL005 Neurilemmoma 60 0.049
101
ISC004 Ischemia 58 0.049
102
CNS004 Constipation 58 0.049
103
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 57 0.049
104
THR024 Thrombosis 57 0.049
105
CYT008 Cytomegalovirus Infection 57 0.049
106
SFT003 Soft Tissue Sarcoma 56 0.049
107
ACS001 Acoustic Neuroma 56 0.049
108
P NRF002 Neurofibromatosis 56 0.049
109
INT007 Intermediate Coronary Syndrome 55 0.049
110
P ART021 Arteriosclerosis 54 0.049
111
c FML008 Familial Retinoblastoma 53 0.049
112
P SML001 Small Cell Carcinoma 52 0.049
113
PNN001 Panniculitis 51 0.049
114
THY125 Thyroid Gland Medullary Carcinoma 50 0.049
115
AGG002 Aggressive Systemic Mastocytosis 49 0.049
116
P RNV001 Renovascular Hypertension 48 0.049
117
SPL018 Splenomegaly 48 0.049
118
c CRB191 Cerebral Cavernous Malformations 2 47 0.049
119
CYT002 Cytokine Deficiency 42 0.049
120
c CRB094 Cerebral Cavernous Malformations 3 42 0.049
121
P RRT020 Rare Tumor 41 0.049
122
c OVR058 Ovarian Small Cell Carcinoma 39 0.049
123
THR123 Thrombotic Microangiopathy 36 0.049
124
SML041 Small-Cell Carcinoma of the Ovary of Hypercalcemic Type 35 0.049
125
CNT018 Central Nervous System Leukemia 34 0.049
126
c ICH023 Ichthyosis, Acquired 30 0.049
127
CVR010 Cavernous Malformation 30 0.049
128
CHR375 Chromosome 8p11 Myeloproliferative Syndrome 29 0.049
Content
Loading form....